Literature DB >> 29637580

The clinical utility of pharmacometric models.

Shaun S Kumar1, Eman Biltaji1,2, Robert Bies3, Catherine M Sherwin1,2.   

Abstract

Mesh：

Year:  2018        PMID： 29637580      PMCID： PMC6005593          DOI： 10.1111/bcp.13603

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN： 0306-5251            Impact factor:   4.335


× No keyword cloud information.
  15 in total

1.  Target concentration intervention: beyond Y2K.

Authors:  N H Holford
Journal:  Br J Clin Pharmacol       Date:  1999-07       Impact factor: 4.335

Review 2.  Clinical trial simulation: a review.

Authors:  N Holford; S C Ma; B A Ploeger
Journal:  Clin Pharmacol Ther       Date:  2010-07-07       Impact factor: 6.875

3.  Leveraging prior quantitative knowledge to guide drug development decisions and regulatory science recommendations: impact of FDA pharmacometrics during 2004-2006.

Authors:  Yaning Wang; A Venkatesh Bhattaram; Pravin R Jadhav; Lawrence J Lesko; Rajanikanth Madabushi; J Robert Powell; Wei Qiu; He Sun; Dong S Yim; Jenny J Zheng; Jogarao V S Gobburu
Journal:  J Clin Pharmacol       Date:  2008-02       Impact factor: 3.126

4.  A comprehensive model for the humoral coagulation network in humans.

Authors:  T Wajima; G K Isbister; S B Duffull
Journal:  Clin Pharmacol Ther       Date:  2009-06-10       Impact factor: 6.875

5.  The pharmacokinetics of metformin and concentrations of haemoglobin A1C and lactate in Indigenous and non-Indigenous Australians with type 2 diabetes mellitus.

Authors:  Janna K Duong; Shaun S Kumar; Timothy J Furlong; Carl M Kirkpatrick; Garry G Graham; Jerry R Greenfield; Ken M Williams; Richard O Day
Journal:  Br J Clin Pharmacol       Date:  2015-04       Impact factor: 4.335

6.  Development of a dosing strategy for enoxaparin in obese patients.

Authors:  Bruce Green; Stephen B Duffull
Journal:  Br J Clin Pharmacol       Date:  2003-07       Impact factor: 4.335

7.  Effect of Australian elapid venoms on blood coagulation: Australian Snakebite Project (ASP-17).

Authors:  Abhishek Gulati; Geoffrey K Isbister; Stephen B Duffull
Journal:  Toxicon       Date:  2012-11-11       Impact factor: 3.033

8.  Population pharmacokinetics of metformin in healthy subjects and patients with type 2 diabetes mellitus: simulation of doses according to renal function.

Authors:  Janna K Duong; Shaun S Kumar; Carl M Kirkpatrick; Louise C Greenup; Manit Arora; Toong C Lee; Peter Timmins; Garry G Graham; Timothy J Furlong; Jerry R Greenfield; Kenneth M Williams; Richard O Day
Journal:  Clin Pharmacokinet       Date:  2013-05       Impact factor: 6.447

9.  Inflammation and Organ Failure Severely Affect Midazolam Clearance in Critically Ill Children.

Authors:  Nienke J Vet; Janneke M Brussee; Matthijs de Hoog; Miriam G Mooij; Carin W M Verlaat; Isabel S Jerchel; Ron H N van Schaik; Birgit C P Koch; Dick Tibboel; Catherijne A J Knibbe; Saskia N de Wildt
Journal:  Am J Respir Crit Care Med       Date:  2016-07-01       Impact factor: 21.405

10.  AUC-Guided Vancomycin Dosing in Adolescent Patients With Suspected Sepsis.

Authors:  Shankar Lanke; Tian Yu; Joseph E Rower; Alfred H Balch; E Kent Korgenski; Catherine M Sherwin
Journal:  J Clin Pharmacol       Date:  2016-07-15       Impact factor: 3.126
View more
  1 in total

1.  The Utility of Pharmacometric Models in Clinical Pharmacology Research in Infants.

Authors:  Guohua An
Journal:  Curr Pharmacol Rep       Date:  2020-08-18
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.